THE BUSINESS OF BIOTECH

1:02:40 24_01_BoB_1280x720_Ep224
Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

While the trend toward CB1 inhibition for obesity took a small hit with the release of Novo Nordisk's small molecule oral cannabinoid receptor (CB1) inverse agonist monlunabant last month, Skye Bioscience Chairman and CEO Punit Dhillon is shaking it off. He's conf...

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Punit Dhillon
Skye Bioscience
PLAY
Allan Shaw
PLAY
Mike Kelly
NervGen Pharma
PLAY
Ali Pashazadeh
Treehill Partners
PLAY
Hilary Eaton
Profluent Bio
PLAY
Simeon George
SR One Capital Management
PLAY
Erik van den Berg
Memo Therapeutics
PLAY
Erik Digman Wiklund
Circio
PLAY
Michael Bailey
AVEO Oncology
PLAY
Apple Spotify   YouTube

MEET THE HOST

Matty PHosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.

LINKEDIN SEND FEEDBACK

Interested in joining us on air? Contact us

bob-nl-tile-v2-350

RECENT EPISODES

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

54:03 24_01_BoB_1280x720_Ep219

Picking Biotech Jockeys With SR One's Simeon George, M.D.

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

1:03:07 24_01_BoB_1280x720_Ep216

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

More podcasts

FINANCE & CAPITAL MARKETS

45:24 24_01_BoB_1280x720_Ep77

The Year's Top Stories With Allan Shaw

30:38 24_01_BoB_1280x720_Ep55

Talking SPAC With Allan Shaw

35:59 24_01_BoB_1280x720_Ep5

Episode 5: Finding Funding In Volatile Times With Ben Zeskind

46:21 24_01_BoB_1280x720_Ep80

Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias

44:34 24_01_BoB_1280x720_Ep4

Episode 4: Building Your Pitch With Leslie Williams

1:08:42 24_01_BoB_1280x720_Ep180

IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel

44:41 24_01_BoB_1280x720_Ep63

From Bayer To Startup Bio With AltruBio's Dr. Judy Chou

55:45 24_01_BoB_1280x720_Ep205

Mission-Driven Dementia Funding with DDF's Jonathan Behr

59:45 24_01_BoB_1280x720_Ep147

Building Flagship Pioneering With Avak Kahvejian, Ph.D.

48:47 24_01_BoB_1280x720_Ep159

Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard

More On Finance & Capital Markets

DISCOVERY

1:01:30 24_01_BoB_1280x720_Ep198

Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.

50:12 24_01_BoB_1280x720_Ep71

Turning The Liver Into A mAb Factory With Homology's Arthur Tzianabos, Ph.D.

55:33 24_01_BoB_1280x720_Ep87

CAR T-cells For Ovarian Cancers with Anixa Biosciences' Amit Kumar, Ph.D.

54:07 24_01_BoB_1280x720_Ep169

Don't Be A D**k With Ochre Bio's Dr. Quin Wills

50:03 24_01_BoB_1280x720_Ep88

Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

39:22 24_01_BoB_1280x720_Ep21

Off-The-Shelf CAR T-Cell Therapy?

48:36 24_01_BoB_1280x720_Ep135

BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.

46:58 24_01_BoB_1280x720_Ep157

ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.

57:04 24_01_BoB_1280x720_Ep79

Precision Approach To Infectious Disease With Locus Biosciences' Paul Garofolo

47:22 24_01_BoB_1280x720_Ep160

Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.

More On Discovery

REGULATORY

37:35 24_01_BoB_1280x720_Ep25

Manipulating Milestones In Pandemic Times With AGTC's Sue Washer

1:06:13 24_01_BoB_1280x720_Ep181

Biotech Down Under with BiomeBank's Dr. Sam Costello

39:58 BoB_Ep42_2

Biopharma Regulatory Requirements With Bluebird Bio's Scott Cleve

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

39:26 24_01_BoB_1280x720_Ep17

Commitment To GMP With Dr. Shabbir Anik

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

38:19 24_01_BoB_1280x720_Ep19

Gap Analysis With Dr. Pablo Valenzuela & Cristián Hernández-Cuevas

37:05 BoB_Ep30_2

Keeping Cell Therapy Clinicals On The Rails With Brian Culley

39:26 24_01_BoB_1280x720_Ep16

Data Quality & Master Files With Dr. Robert Hariri

1:12:31 24_01_BoB_1280x720_Ep209

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

More On Regulatory

MANUFACTURING

35:43 BoB_1280x720_Ep9

Solving The COVID-19 Workforce Crisis

51:41 24_01_BoB_1280x720_Ep182

CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees

36:21 24_01_BoB_1280x720_Ep6

Episode 6: Building An All-Star Biotech Team With Vivek Ramaswamy

35:29 BoB_Ep65_2

CDMO With A Pipeline Featuring Forge Biologics President & CEO Dr. Timothy J. Miller

1:01:16 24_01_BoB_1280x720_Ep116

Regenerative Wound Care With BioStem Technologies' Jason Matuszewski & Andrew VanVurst

38:36 BoB_Ep39_2

mAb Manufacturing with Rezolute Bio's Nevan Charles Elam, JD

42:30 BoB_Ep_38_2

Cell Therapy Platform Dev With Precigen CEO Dr. Helen Sabzevari

40:46 24_01_BoB_1280x720_Ep24

Gene Therapy Manufacturing At-Scale With Geoff MacKay

56:54 24_01_BoB_1280x720_Ep197

Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

More On Manufacturing